BSE filing, NSE: MACINTR. Summary written from the filing by ALFA Finder's alert engine.
Astal Laboratories Ltd: key numbers
- Share price
- ₹59.50
- Market cap
- ₹251.2 Cr
- Revenue (annual)
- ₹156.0 Cr
- Net profit (annual)
- ₹8.12 Cr
- P/E (TTM)
- 25.8×Sector 46.8×
- Promoter holding
- 4.59%+0.06% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Astal Laboratories Ltd
All →Astal Laboratories Board Meeting Date
Astal Laboratories will hold a board meeting on 13 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The trading window stays closed until 48 hours after the meeting.
Astal Laboratories Other Announcement
Astal Laboratories submitted the Regulation 74(5) certificate from its Registrar for the quarter ended September 30, 2026, confirming the dematerialization activities.
Astal Laboratories Other Announcement
Astal Laboratories' material subsidiary, Sriven Pharmachem India, appointed new Internal, Cost, and Secretarial Auditors. The appointments were approved during the subsidiary's board meeting on September 28, 2026.
Astal Laboratories Management Change
Astal Laboratories Limited has appointed Ms. Ambika Kedia as Company Secretary of its material wholly-owned subsidiary, Sriven Pharmachem India Private Limited. The appointment is effective from September 28, 2026.
Astal Laboratories Annual General Meeting
Astal Laboratories held its 33rd Annual General Meeting on September 29, 2026. Members transacted business regarding financial statements and the re-appointment of a director.
Astal Laboratories Promoter Buying: ₹0.2 Cr
Promoter Aceso Research Labs LLP acquired 25,417 equity shares of Astal Laboratories Ltd via market purchase, increasing their stake from 4.53% to 4.59%.
- Value
- ₹0.20 Cr
- Promoter stake change
- +0.06%
Other board meeting date announcements
All →KS Smart Technologies Board Meeting Date
KS Smart Technologies will hold a board meeting on 13 November 2026 to approve unaudited results. The trading window stays closed until results are disseminated.
BharatRohan Airborne Innovations Board Meeting Date
BharatRohan Airborne Innovations gave notice of a board meeting on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The meeting has not yet been held and no results are attached.
Dolphin Medical Services Board Meeting Date
Dolphin Medical Services has notified BSE of a board meeting on 14 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after results publication.
Jungle Camps India Board Meeting Date
Jungle Camps India schedules a board meeting on November 13, 2026 to approve September 2026 quarter and half-year results. Trading window stays closed until November 15.
Zetwerk Manufacturing Businesses Board Meeting Date
Zetwerk Manufacturing will hold a board meeting on 13 November 2026 to consider September quarter results. Trading window stays closed until 48 hours after results are public.
Lovable Lingerie Board Meeting Date
Lovable Lingerie will hold a board meeting on 14 November 2026 to consider unaudited quarterly results for September 2026. Trading window is closed from 1 October 2026 until 16 November 2026.